Natural History of Prostatism: Relationship Among Symptoms, Prostate Volume and Peak Urinary Flow Rate

The Journal of Urology

Volumn 153, Issue 5, 1995, Pages 1510-1515

  Girman, Cynthia J ^a   Jacobsen, Steven J ^a   Guess, Harry A ^a   Oesterling, Joseph E ^a   Chute, Christopher G ^a   Panser, Laurel A ^a   Lieber, Michael M ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE SEVERITY; ECHOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICTURITION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATISM; STATISTICAL ANALYSIS; URINE FLOW RATE;

COHORT STUDIES; CROSS-SECTIONAL STUDIES; HUMAN; LEAST-SQUARES ANALYSIS; MALE; MIDDLE AGE; MINNESOTA; MULTIVARIATE ANALYSIS; PROSTATE; PROSTATIC HYPERPLASIA; RANDOM ALLOCATION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; URODYNAMICS;

EID: 0028965747     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)67448-2     Document Type: Article

References (52)

1. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia.
2. Some clinical aspects of uroflowmetry in elderly males. A population survey.
3. Significance of prostate weight in prostatism.
4. The significance of symptoms associated with bladder outflow obstruction.
5. Controversies about indications for transurethral resection of the prostate.
6. Clinical manifestations of benign prostatic hyperplasia and indications for therapeutic intervention.
7. Urodynamics in benign prostatic hyperplasia: a survey.
8. Prostatism. I. The correlation between symptoms, cystometric and urodynamic findings.
9. The relevance of minimum urethral resistance in prostatism.
10. Clinical evaluation of routine urodynamic investigations in prostatism
11. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests.
12. A population-based study of health care-seeking behavior for treatment of urinary symptoms. The Olmsted County study of urinary symptoms and health status among men.
13. Referral selection bias in the Medicare hospital mortality prediction model: are centers of referral for Medicare beneficiaries necessarily centers of excellence?
14. Sample selection and the natural history of disease--studies of febrile seizures.
15. The prevalence of prostatism: a population-based survey of urinary symptoms.
16. Similar levels of urological symptoms have similar impact on Scottish and American men--although Scots report less symptoms.
17. Population studies in Rochester and Olmsted County, Minnesota, 1900-1968
18. The patient record in epidemiology.
19. Validation of a new quality of life questionnaire for benign prostatic hyperplasia.
20. Natural history of prostatism: urinary flow rates in a community-based study.
21. Serum prostate specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges.
22. The American Urological Association symptom index for benign prostatic hyperplasia.
23. Indications for treatment of benign prostatic hyperplasia. The American Urological Association study.
24. The assessment of prostatic obstruction from urodynamic measurements and from residual urine.
25. Cholesterol and coronary artery disease: age as an effect modifier.
26. Measurement characteristics of three asthma symptom diaries validated in three separate studies of mild to moderate asthma patients.
27. Calcium intake and the relationship of dietary sodium and potassium to blood pressure.
28. Linking clinical variables with health-related quality of life.
29. Alternatives to surgery for benign prostatic hyperplasia.
30. Benign prostatic hyperplasia: the scope of the problem.
31. Analysis of presenting symptoms of prostatism.
32. Association between symptomatology and uroflowmetry in BPH.
33. Variability and circadian changes in home uroflowmetry in patients with benign prostatic hyperplasia compared to normal controls.
34. A comparison of quality of life with patient reported symptoms and objective findings in men with benign prostatic hyperplasia.
35. Objective and subjective response criteria to diagnose benign prostatic hyperplasia.
36. Benign prostatic hyperplasia: antecedents and natural history.
37. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen.
38. Using repeated measures of symptom score, uroflow and prostate specific antigen in the clinical management of prostate disease.
39. Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age.
40. American Urological Association symptom index for women with voiding symptoms: lack of index specificity for benign prostate hyperplasia.
41. Specificity of the American Urological Association voiding symptom index: comparison of unselected and selected samples of both sexes.
42. Importance of the natural history of benign prostatic hyperplasia in the evaluation of pharmacologic intervention.
43. Benign prostatic hyperplasia and its treatment
44. Effect of several recruitment strategies on response rates at baseline in a prospective cohort investigation: the Olmsted County study of urinary symptoms and health status among men.
45. The natural history of prostatism: the effects of non-response bias.